Anteris Technologies Ltd (AMEUF)
13.50
+0.35
(+2.66%)
USD |
OTCM |
May 21, 16:00
Anteris Technologies Enterprise Value: 238.66M for May 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 21, 2024 | 238.66M |
May 20, 2024 | 231.93M |
May 17, 2024 | 249.23M |
May 16, 2024 | 249.23M |
May 15, 2024 | 249.23M |
May 14, 2024 | 249.23M |
May 13, 2024 | 249.06M |
May 10, 2024 | 255.01M |
May 09, 2024 | 261.55M |
May 08, 2024 | 261.55M |
May 07, 2024 | 261.55M |
May 06, 2024 | 261.55M |
May 03, 2024 | 261.55M |
May 02, 2024 | 261.55M |
May 01, 2024 | 261.55M |
April 30, 2024 | 261.55M |
April 29, 2024 | 261.55M |
April 26, 2024 | 261.55M |
April 25, 2024 | 261.55M |
April 24, 2024 | 261.55M |
April 23, 2024 | 277.49M |
April 22, 2024 | 277.49M |
April 19, 2024 | 277.49M |
April 18, 2024 | 277.49M |
April 17, 2024 | 261.96M |
Date | Value |
---|---|
April 16, 2024 | 261.73M |
April 15, 2024 | 261.73M |
April 12, 2024 | 260.17M |
April 11, 2024 | 260.17M |
April 10, 2024 | 260.17M |
April 09, 2024 | 260.17M |
April 08, 2024 | 260.17M |
April 05, 2024 | 260.17M |
April 04, 2024 | 260.17M |
April 03, 2024 | 254.20M |
April 02, 2024 | 254.20M |
April 01, 2024 | 234.12M |
March 28, 2024 | 234.12M |
March 27, 2024 | 234.12M |
March 26, 2024 | 234.11M |
March 25, 2024 | 234.11M |
March 22, 2024 | 234.11M |
March 21, 2024 | 234.11M |
March 20, 2024 | 216.74M |
March 19, 2024 | 214.38M |
March 18, 2024 | 214.38M |
March 15, 2024 | 214.38M |
March 14, 2024 | 214.38M |
March 13, 2024 | 211.78M |
March 12, 2024 | 211.78M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-4.043M
Minimum
Mar 02 2020
277.49M
Maximum
Apr 18 2024
116.55M
Average
90.89M
Median
Jun 04 2019
Enterprise Value Benchmarks
Alterity Therapeutics Ltd | -- |
Kazia Therapeutics Ltd | 5.246M |
Immutep Ltd | -- |
Opthea Ltd | 123.80M |
Mesoblast Ltd | -- |
Enterprise Value Related Metrics
Earnings Yield | -21.04% |
Normalized Earnings Yield | -21.04 |